| |
The National Institute of Mental Health (NIMH)
is seeking input from the clinical research community, mental health
professionals, patient advocates and individuals living with mental
illnesses, private and public mental health service systems and
providers, the pharmaceutical and biotechnology industry, and other
interested groups about important public mental health research
questions that could be addressed using the infrastructure provided
by three NIMH clinical research networks - the Bipolar Trials Network
(BTN), the Depression Trials Network (DTN), and the Schizophrenia
Trials Network (STN).
Click
here for additional information.
|